Appetite Depressants
-
Subject Areas on Research
- Analysis of clinical data with breached blindness.
- C75 inhibits food intake by increasing CNS glucose metabolism.
- Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation.
- Clinical experience using appetite suppressants and SSRIs.
- D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell.
- Dieting status and its relationship to eating and physical activity behaviors in a representative sample of US adolescents.
- Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies.
- Effect of moderate weight loss on health-related quality of life: an analysis of combined data from 4 randomized trials of sibutramine vs placebo.
- Effects of phentermine and phenformin on biomarkers of aging in rats.
- Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity.
- Fenfluramine and phentermine and cardiovascular findings: effect of treatment duration on prevalence of valve abnormalities.
- Insulin Detemir Is Transported From Blood to Cerebrospinal Fluid and Has Prolonged Central Anorectic Action Relative to NPH Insulin.
- Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.
- Pharmaceutical interventions for obesity: a public health perspective.
- Pharmacological and surgical treatments for obesity.
- Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity.
- Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication.
- Session highlights from the American College of Cardiology Scientific Sessions: March 29 to April 1, 1998.
- Suppression of alcohol and saccharin preference in rats by a novel Ca2+ channel inhibitor, Goe 5438.
- The efficacy of the appetite suppressant, diethylpropion, is dependent on both when it is given (day vs. night) and under conditions of high fat dietary restriction.
- The progression of fenfluramine-associated valvular heart disease assessed by echocardiography.
- The relationship between health-related quality of life and weight loss.